Approval was based on the FLOW clinical trial
As semaglutide access continues to evolve, FDA-recognized options in 2026 reflect a broader trend toward individualized weight management strategies supported by medical governance rather than one-size-fits-all solutions
Medical Weight Loss Frequently Asked Questions Tirzepatide is effective in promoting significant weight loss in individuals struggling with obesity or who are overweight
Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin
Unlike other GLP-1 agonists like Tirzepatide, which activate two receptors (GIP + GLP-1), Retatrutide targets three hormone receptors: GIP, GLP-1, and Glucagon receptors
If itching persists beyond 34 weeks, intensifies with each injection, or is accompanied by warmth, pus, or increasing redness, contact a healthcare provider to rule out infection or cellulitis